Nephrol Dial Transplant (1999) 14: 1834-1835
© 1999 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Antithrombotic measures for indwelling intravenous haemodialysis catheters—Columbus' egg yet to be found
Departments of Internal Medicine and 1 Surgery, Academisch Ziekenhuis Maastricht, The Netherlands
Correspondence and offprint requests to: J. N. M. Barendregt, Department of Nephrology, Maastricht University Hospital, PO Box 5800, 6202 AZ Maastricht, The Netherlands.
Catheter thrombosis—the Achilles heel
Few expressions are used more often in haemodialysis literature than that vascular access is essential for adequate extracorporeal renal replacement therapy. In the absence of an arteriovenous access site it is common practice to use indwelling venous catheters, usually inserted in the jugular, femoral or subclavian vein. Scribner shunts appear to be used much less frequently than in the early years of dialysis. Usually catheters contain a single or double lumen, are cuffed or non-cuffed to help prevent catheter-related infection, and consist of polyurethane, polyethylene or silicone, the latter being more flexible and less
Heparin—how much, how often?
Alternatives to heparin?
Anti-coagulation to prevent peri-catheter thrombosis?
Studies required to resolve these issues
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Karaaslan, P. Peyronnet, D. Benevent, C. Lagarde, M. Rince, and C. Leroux-Robert Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis Nephrol. Dial. Transplant., October 1, 2001; 16(10): 2072 - 2074. [Abstract] [Full Text] [PDF]
|
|